IOSP vs PATH · P/E 18, rev $1.78B vs P/E 19, rev $1.61B
Innospec Inc (IOSP) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Innospec Inc (IOSP) is a specialty chemicals company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IOSP revenue for 2025-12-31 was $1.78B. Net income was $116.6M. Revenue was down 3.7% from 2024-12-31 to 2025-12-31. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IOSP currently screens at market cap $2.05B and trailing P/E 18.1. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IOSP and PATH stock pages for the full models.
Not investment advice.